Indeed, consistent with the hypothesis that this subset of stromal cells makes a significant contribution to the physical barriers and functional inhibition of anti-tumor immunity, we and others demonstrated that CAR T cells targeted to fibroblast activation protein (FAP-CAR T) on FAP-expressing stromal cells can effectively inhibit tumor growth in mouse models of solid tumors9,11,16. Here, FAP is linked to neoplasm.